Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381596 · ClinicalTrials.gov registry record · NA
Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06381596 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 33 participants.
The verdict
NCT06381596, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the areas of stressed cells in the retina correlate to areas of disease identified in standard imaging and whether the images are helpful to identify potential areas of concern before symptoms or disease occurs. The main question it aims to answer is: * to evaluate patterns of increased autofluorescence FPF in the setting of geographic atrophy Participants will undergo FPF imaging using the OcuMet Beacon system.
Interventions
- DEVICE OcuMet Beacon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06381596
The ClinicalTrials.gov registry entry for NCT06381596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OcuMet Beacon is the first listed.
NCT06381596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06381596 about?
NCT06381596 is a clinical study titled "Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration". The goal of this clinical trial is to learn if the areas of stressed cells in the retina correlate to areas of disease identified in standard imaging and whether the images are helpful to identify potential areas of concern before symptoms or disease occurs. The main question it aims to answer is: ...
What is the current status of trial NCT06381596?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-04-16. Estimated completion is 2025-05-27.
What interventions are being tested in trial NCT06381596?
The interventions under investigation include: OcuMet Beacon (DEVICE).
Who is sponsoring clinical trial NCT06381596?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.